Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.23.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.466.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.213NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.56 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.14 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.359NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.8 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.440NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.104 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.198NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.17.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.375NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBDNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CN.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.576NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.325NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.378NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.206NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used